Exclusive: AstraZeneca U.S. COVID-19 vaccine trial may resume as soon as this week – sources
CHICAGO/WASHINGTON (Reuters) – AstraZeneca Plc’s COVID-19 vaccine trial in the United States is expected to resume as early as this
Read more
AstraZeneca U.S